首页> 外文OA文献 >Antiidiotypic antibodies against a platelet reactive IgG Fab cloned from a combinatorial antibody library of a healthy individual
【2h】

Antiidiotypic antibodies against a platelet reactive IgG Fab cloned from a combinatorial antibody library of a healthy individual

机译:从健康个体的组合抗体库中克隆的针对血小板反应性IgG Fab的抗独特型抗体

摘要

Since many years, intravenously administered IgG antibodies (IVIG) prepared from plasma of numerous healthy blood donors are successfully used in the therapy of autoimmune thrombocytopenia (AITP) and other autoimmune diseases. IVIG`s mechanism of action seems to be complex and is not clearly clarified yet. Both Fc-receptor dependent effects and immunmodulatory antiidiotypic effects based on the antigen-binding sites, the so called Fab fragments, were discussed to play a role. Applying phage display and antiidiotypic biopanning with IVIG to investigate the antiidiotypic effects of IVIG on the immune system, the group of PD Dr. Peter Fischer had cloned and characterized many platelet reactive human IgG Fab fragments from patients with AITP for the first time. The platelet reactive Fab fragments originated predominantly from the VH-4 germline gene family. However, the VH germline genes 3-23 and 3-30 represented the most frequent genetic origin of the variable region of the heavy chain regarding the platelet-negative, IVIG selected clones from autoimmune patients and from a healthy individual. Interestingly, the CDR3-region and the light chains seemed to have no influence on the selection by IVIG, likewise there was no accumulation of certain DH- and JH-germline genes.The fact that IVIG preferably bound antibodies originating from the germline gene segments 3-30 and 3-23 independent of a certain disease together with other results suggested a fundamental meaning of these interaction for the regulation of the B-cell repertoire. This led to the hypothesis that IVIG may regulate the B-cell repertoire over a B-cell-superantigen-like-function besides the direct binding of autoantibodies. In order to get more information about the potential regulating molecules of IVIG and to reach a possible clinical relevance it was the goal of this study to clone the therapeutically relevant molecules from IVIG. For that purpose the IVIG-targets described above and a Fab-Phage-library of a healthy donor (as representative for IVIG) which were already established by the group of PD Dr. Peter Fischer should be used. The structural and functional characterisation of the isolated clones afterwards should made the possible antiidiotypic mechanism of IVIG more clear.Fab presenting phage clones originating from an IgG library of a healthy individual and isolated by binding to a platelet reactive Fab fragment of the VH 3-30 gene family (LO31) isolated previously with IVIG could be cloned by means of phage display and biopanning technique. Sequencing of four LO31-binding Fab phage clones, which displayed a different BstNI restriction pattern, revealed the genetic identity of three clones originating from VH4-61 and VL2a2. The fourth clone showed a VH1-02 and VL2a2 germline gene origin.When sequences were compared at DNA and protein level a great variability of the CDRs as well as framework regions was revealed. The CDRs not only differed in their amino-acid patterns but also partially in their length. Determination of mutation rates from CDRs and framework regions by comparison with germline genes and the relation between replacement and silent mutations led to the conclusion that mutations of the germline genes were antigen driven. To characterise the binding properties of the LO31 binding Fab phages, soluble Fab fragments with differing binding specificities and partially differing genetic origin were large-scale produced and purified. Subsequent binding assays demonstrated that isolated Fab phages bound specifically to the Fab fragments by which they had been isolated. Other Fab fragments bound only weak or not at all. Binding to Fc fragment was not detectable. As a result, the isolated Fab fragments did not bind multiple VH3-30 or VH3-23 originating antibodies but were true antiidiotypic antibodies against a single antibody.In conclusion, two Fab fragments which interact highly specifically/antiidiotypically with a single IVIG-selected Fab were successfully isolated from an IgG library of a healthy individual. They did not represent the postulated subset from IVIG, representing a B cell superantigen, which binds outside of the antigen binding site to multiple B-cell receptors, but refers to antibodies, which - as individual idiotyps – bind rather as Ab2 beta or gamma. The reason may have been the very restricted panning procedures. The isolated Fab fragments might represent antibodies from IVIG with thrombocyte autoantibody-blocking properties and hence inhibit the autoantibody caused destruction of the thrombocytes.
机译:多年来,从众多健康献血者血浆中制备的静脉注射IgG抗体(IVIG)已成功用于自身免疫性血小板减少症(AITP)和其他自身免疫性疾病的治疗。 IVIG的作用机制似乎很复杂,尚未明确阐明。讨论了Fc受体依赖性作用和基于抗原结合位点的免疫调节抗独特型作用,即所谓的Fab片段,它们都发挥作用。 PD小组的Peter Fischer博士运用噬菌体展示和IVIG的抗独特型生物淘选研究了IVIG对免疫系统的抗独特性作用,这是PD小组的Peter Fischer博士首次克隆并鉴定了AITP患者的许多血小板反应性人IgG Fab片段。血小板反应性Fab片段主要来自VH-4种系基因家族。但是,VH种系基因3-23和3-30代表了重链可变区的最常见遗传起源,这是针对来自自身免疫患者和健康个体的血小板阴性,IVIG选择的克隆。有趣的是,CDR3区和轻链似乎对IVIG的选择没有影响,同样也没有某些DH-和JH-germline基因的积累.IVIG优选结合了源自种系基因片段的抗体3 -30和3-23与某种疾病无关,以及其他结果表明,这些相互作用对于B细胞库的调节具有根本意义。这导致了一个假说,即IVIG除了可以直接结合自身抗体外,还可以通过B细胞超抗原样功能来调节B细胞库。为了获得有关IVIG潜在调节分子的更多信息并达到可能的临床相关性,本研究的目标是从IVIG中克隆治疗相关分子。为此,应使用PD小组的Peter Fischer博士已经建立的上述IVIG靶标和健康供体的Fab-Phage库(作为IVIG的代表)。随后分离的克隆的结构和功能表征应使IVIG的可能的抗独特型机制更加清晰.Fab呈递噬菌体克隆源自健康个体的IgG文库,并通过与VH 3-30的血小板反应性Fab片段结合而分离可以通过噬菌体展示和生物淘选技术克隆先前与IVIG分离的基因家族(LO31)。四个LO31结合Fab噬菌体克隆的测序,显示了不同的BstNI限制模式,揭示了源自VH4-61和VL2a2的三个克隆的遗传同一性。第四个克隆显示了VH1-02和VL2a2种系基因的起源。当在DNA和蛋白质水平比较序列时,发现CDR和构架区的变异性很大。 CDR不仅氨基酸模式不同,而且长度也部分不同。通过与种系基因进行比较来确定CDR和构架区的突变率,以及置换突变与沉默突变之间的关系得出结论:种系基因的突变是抗原驱动的。为了表征LO31结合Fab噬菌体的结合特性,大规模生产和纯化了具有不同结合特异性和部分不同遗传起源的可溶性Fab片段。随后的结合测定法证明,分离的Fab噬菌体特异性结合了已经被分离的Fab片段。其他Fab片段仅弱结合或根本不结合。与Fc片段的结合是不可检测的。结果,分离出的Fab片段不结合多个VH3-30或VH3-23起源的抗体,而是针对单个抗体的真正抗独特型抗体。总而言之,两个Fab片段与单个IVIG选择的Fab高度特异性/抗典型地相互作用从健康个体的IgG文库中成功分离得到。它们并不代表IVIG的假定子集,后者代表B细胞超抗原,它在抗原结合位点之外与多​​个B细胞受体结合,但指的是抗体,作为个体独特型,其结合而不是Ab2 beta或γ。原因可能是平移程序非常受限。分离的Fab片段可能代表来自IVIG的具有血小板自身抗体阻断特性的抗体,因此抑制了自身抗体引起的血小板破坏。

著录项

  • 作者

    Gluschke Manuela;

  • 作者单位
  • 年度 2010
  • 总页数
  • 原文格式 PDF
  • 正文语种 deu
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号